<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16813</article-id><article-id pub-id-type="doi">10.25208/vdv16813</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАУЧНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessment of <italic>T. pallidum</italic> recombinant proteins Tp0163 and Tp0971 as antigens for the diagnosis of syphilis by enzyme-linked immunosorbent assay</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка рекомбинантных белков <italic>T. pallidum</italic> Тр0163 и Тр0971 как антигенов для диагностики сифилиса методом иммуноферментного анализа</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-9343-7191</contrib-id><name-alternatives><name xml:lang="en"><surname>Arbuzova</surname><given-names>Natalia V.</given-names></name><name xml:lang="ru"><surname>Арбузова</surname><given-names>Наталья Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Chemist</p></bio><bio xml:lang="ru"><p>химик</p></bio><email>arbuzova@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9957-4009</contrib-id><contrib-id contrib-id-type="spin">6600-3311</contrib-id><name-alternatives><name xml:lang="en"><surname>Shpilevaya</surname><given-names>Marina V.</given-names></name><name xml:lang="ru"><surname>Шпилевая</surname><given-names>Марина Валентиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology), Senior Researcher</p></bio><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник</p></bio><email>aniram1970@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0599-6305</contrib-id><contrib-id contrib-id-type="spin">1598-8595</contrib-id><name-alternatives><name xml:lang="en"><surname>Katunin</surname><given-names>Georgii L.</given-names></name><name xml:lang="ru"><surname>Катунин</surname><given-names>Георгий Леонидович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>g.katunin@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7571-7108</contrib-id><contrib-id contrib-id-type="spin">8600-3098</contrib-id><name-alternatives><name xml:lang="en"><surname>Kuznetsov</surname><given-names>Oleg E.</given-names></name><name xml:lang="ru"><surname>Кузнецов</surname><given-names>Олег Евгеньевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>k-o-e@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3967-8359</contrib-id><contrib-id contrib-id-type="spin">8806-8539</contrib-id><name-alternatives><name xml:lang="en"><surname>Nosov</surname><given-names>Nikita Yu.</given-names></name><name xml:lang="ru"><surname>Носов</surname><given-names>Никита Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology), Leading Researcher</p></bio><bio xml:lang="ru"><p>к.б.н., ведущий научный сотрудник</p></bio><email>nnosov@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6841-8599</contrib-id><contrib-id contrib-id-type="spin">1486-3284</contrib-id><name-alternatives><name xml:lang="en"><surname>Solomka</surname><given-names>Viсtoria  S.</given-names></name><name xml:lang="ru"><surname>Соломка</surname><given-names>Виктория Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>д.б.н.</p></bio><email>solomka@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-11-25" publication-format="electronic"><day>25</day><month>11</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2024</year></pub-date><volume>100</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>53</fpage><lpage>60</lpage><history><date date-type="received" iso-8601-date="2024-08-01"><day>01</day><month>08</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-11-20"><day>20</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Natalia V. Arbuzova, Marina V. Shpilevaya, Georgii L. Katunin, Oleg E. Kuznetsov, Nikita Yu. Nosov, Viktoriya S. Solomka</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Арбузова Н.В., Шпилевая М.В., Катунин Г.Л., Кузнецов О.Е., Носов Н.Ю., Соломка В.С.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Natalia V. Arbuzova, Marina V. Shpilevaya, Georgii L. Katunin, Oleg E. Kuznetsov, Nikita Yu. Nosov, Viktoriya S. Solomka</copyright-holder><copyright-holder xml:lang="ru">Арбузова Н.В., Шпилевая М.В., Катунин Г.Л., Кузнецов О.Е., Носов Н.Ю., Соломка В.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/16813">https://vestnikdv.ru/jour/article/view/16813</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>Genomic sequencing of <italic>T. pallidum </italic>and the application of bioinformatics and immunoproteomics resulted in many recombinant proteins of <italic>T. pallidum</italic> that have been analyzed for their diagnostic value, and some of them are used as diagnostic antigens in commercial tests. However, in practice, there are often significant difficulties in the diagnosis of asymptomatic forms of syphilis, especially of the late forms, when the sensitivity of serological methods may differ significantly. Therefore, the search for more sensitive and specific antigens for serological diagnosis of syphilis is ongoing.</p> <p><bold>Aim of study.</bold> Assessment of the potential of <italic>T. pallidum</italic> recombinant proteins Tp0163 and Tp0971 as candidate antigens for serum IgG determination in syphilis patients by enzyme-linked immunosorbent assay (ELISA).</p> <p><bold>Methods.</bold> <italic>T. pallidum</italic> recombinant proteins Tp0163 and Tp0971 were produced by Cusabio (China). Serum samples from subjects with a confirmed diagnosis of primary, secondary, early latent and late latent syphilis, as well as serum samples from healthy subjects as controls were used for the tests with indirect ELISA. To characterize the antibody concentration, a positivity coefficient equal to the ratio of the absorbance obtained for each sample to the critical absorbance was determined. The positivity coefficient was used to determine the difference between groups of syphilis patients and healthy individuals using the Mann-Whitney test for unpaired samples, and to assess the clinical informativeness of laboratory test. The diagnostic efficacy of ELISA was assessed by calculating the values in groups of patients with established diagnosis of syphilis and in a group of healthy individuals in compliance with the standard assessment of the diagnostic informativeness of laboratory tests.</p> <p><bold>Results.</bold> The overall diagnostic efficacy of the studied recombinant proteins for the detection of IgG class antibodies by ELISA is 65.4 and 66.7 % for Tp0163 and Tp0971, respectively, demonstrating high specificity and positive predictive value of the test. The sensitivity of ELISA to the studied forms of syphilis does not exceed 68.8 %.</p> <p><bold>Conclusion. </bold>In<bold> </bold>order to improve treponema-specific diagnosis of syphilis, we believe it is important to continue working with these antigens to determine the efficacy of ELISA to detect IgG, IgM, or IgM/IgG antibody ratios with more clinical serum samples from subjects with syphilis, subjects without clinical and laboratory signs of syphilis, and healthy individuals.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>С расшифровкой генома <italic>T. pallidum</italic> и применением биоинформатики и иммунопротеомики появилось множество рекомбинантных белков <italic>T. pallidum</italic>, которые были проанализированы с точки зрения их диагностической ценности, и некоторые из них используются в качестве диагностических антигенов в коммерческих тестах. Однако на практике нередко возникают существенные затруднения при диагностике асимптомных форм сифилиса, особенно поздних, когда чувствительность серологических методов может значительно различаться. Поэтому поиск более чувствительных и специфических антигенов для серологической диагностики сифилиса продолжается.</p> <p><bold>Цель исследования. </bold>Оценка потенциала рекомбинантных белков <italic>T. </italic><italic>pallidum</italic> Тр0163 и Тр0971 в качестве кандидатных антигенов для определения IgG в сыворотке больных сифилисом методом иммуноферментного анализа (ИФА).</p> <p><bold>Методы. </bold>Рекомбинантные белки <italic>T. </italic><italic>pallidum</italic> Тр0163 и Тр0971 произведены фирмой Cusabio (Китай). Для исследования методом непрямого ИФА использовали образцы сыворотки крови пациентов с подтвержденным диагнозом первичного, вторичного, раннего скрытого и позднего скрытого сифилиса, а также образцы сыворотки крови от здоровых лиц как группы контроля. Для характеристики концентрации антител определяли коэффициент позитивности, равный отношению оптической плотности, полученной для каждого образца, к критической оптической плотности. Коэффициент позитивности использовали для определения различия между группами больных сифилисом и здоровых лиц по критерию Манна–Уитни для непарных выборок, а также для оценки клинической информативности лабораторного теста. Оценку диагностической эффективности ИФА проводили путем расчета показателей в группах больных с установленным диагнозом сифилиса и в группе здоровых лиц в соответствии со стандартом оценки диагностической информативности лабораторных тестов.</p> <p><bold>Результаты. </bold>Общая диагностическая эффективность исследованных рекомбинантных белков для определения антител класса IgG методом ИФА составляет 65,4 и 66,7% соответственно для Тр0163 и Тр0971, демонстрируя при этом высокую специфичность и положительную предсказательную ценность исследования. Чувствительность ИФА в отношении изученных форм сифилиса не превышает 68,8%.</p> <p><bold>Заключение.</bold> С целью совершенствования трепонема-специфической диагностики сифилиса мы считаем важным продолжить работу с данными антигенами по определению эффективности ИФА для выявления IgG, IgМ или соотношения антител IgM/IgG с большим количеством клинических образцов сывороток от пациентов с сифилисом, пациентов без клинико-лабораторных признаков сифилиса и здоровых лиц.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Treponema pallidum</kwd><kwd>recombinant proteins</kwd><kwd>Тр0163</kwd><kwd>Тр0971</kwd><kwd>enzyme-linked immunosorbent assay</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Treponema pallidum</kwd><kwd>рекомбинантные белки</kwd><kwd>Тр0163</kwd><kwd>Тр0971</kwd><kwd>иммуноферментный анализ</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was carried out within the framework of the state task of the State Research Center of Dermatovenereology and Cosmetology of the Ministry of Health of Russia No. 056-00003-24-02 for 2024.</funding-statement><funding-statement xml:lang="ru">Рукопись подготовлена и опубликована в рамках выполнения государственного задания ФГБУ «ГНЦДК» Минздрава России № 056-00003-24-02 на 2024 г.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wong EH, Klausner JD, Caguin-Grygiel G, Madayag C, Barber KO, Qiu JS, et al. Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population. Sex Transm Dis. 2011;38(6):528–532. doi: 10.1097/OLQ.0b013e318205491a</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>McGill MA, Edmondson DG, Carroll JA, Cook RG, Orkiszewski RS, Norris SJ. Characterization and serologic analysis of the Treponema pallidum proteome. Infect Immun. 2010;78(6):2631–2643. doi: 10.1128/IAI.00173-10</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Brinkman MB, McKevitt M, McLoughlin M, Perez C, Howell J, Weinstock GM, et al. Reactivity of antibodies from syphilis patients to a protein array representing the Treponema pallidum proteome. J Clin Microbiol. 2006;44(3):888–891. doi: 10.1128/JCM.44.3.888-891.2006</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Хайруллин Р.Ф., Ротанов С.В., Фриго Н.В., Белоусова А.В. Биоинформатический анализ специфических антигенов T. pallidum. Вестник дерматологии и венерологии. 2012;5:56–64. [Khairullin RF, Rotanov SV, Frigo NV, Belousova AV. Bioinformatic analysis of the specific antigens of T. pallidum. Journal of Dermatology and Venereology. 2012;5:56–64. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Рунина А.В., Хайруллин Р.Ф., Рог К.В., Семина В.И., Ротанов С.В. Новые рекомбинантные антигены T. pallidum Tp0453 и Tp0319 в диагностике сифилиса. Вестник дерматологии и венерологии. 2014;3:72–78. [Runina AV, Khairullin RF, Rog KV, Semina VI, Rotanov SV. New recombinant T. pallidum antigens Tp0453 and Tp0319 in the diagnostics of syphilis. Vestnik Dermatologii i Venerologii 2014;3:72–78. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Рунина А.В., Затевалов А.М., Катунин Г.Л., Дерябин Д.Г., Кубанов А.А. Варьирование иммунного ответа на антигены Tр0277, Tр 0684, Tр 0965 и Tр 1038 Treponema pallidum при различных формах сифилиса. Российский иммунологический журнал. 2017;11(1):70–78. [Runina AV, Zatevalov AM, Katunin GL, Deryabin DG, Kubanov AA. Variation of immune response to Tp0277, Tp 0684, Tp 0965 and Tp 1038 Treponema pallidum antigens in different syphilis stages. Russian Journal of Immunology. 2017;1(1):70–78. (In Russ.)]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Runina AV, Katunin GL, Filippova MA, Zatevalov AM, Kubanov AA, Deryabin DG. 2018. Immunochip for syphilis serodiagnostics with the use of extended array of Treponema pallidum recombinant antigens. Bull Exp Biol Med. 2018;165(6):767–771. doi: 10.1007/s10517-018-4261-0</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Рунина А.В., Рог К.В., Васильев М.М. ТрF1 — новый потенциальный антиген для серодиагностики скрытых форм сифилитической инфекции. Вестник дерматологии и венерологии. 2014;6:86–92. [Runina AV, Rog KV, Vasiliev MM. TpF1 — new potential antigen for serodiagnosis of latent forms of syphilis infection. Journal of Dermatology and Venereology. 2014;6:86–92. (In Russ.)]</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Рунина А.В., Старовойтова А.С., Дерябин Д.Г., Кубанов А.А. Рекомбинантный белок Tp0965 Treponema pallidum как перспективный антиген для совершенствования серологической диагностики сифилиса. Вестник РАМН. 2016;71(2):109–113. [Runina AV, Starovoitova AS, Deryabin DG, Kubanov AA. Evaluation of the recombinant protein Tp0965 of Treponema pallidum as candidate antigen for serological diagnosis of syphilis. Annals of the Russian Academy of Medical Sciences. 2016;71(2):109–113. (In Russ.)] doi: 10.15690/vramn653</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Campo JJ, Romeis ER, Oberai A, Pablo JV, Hung C, Teng AA, et al. A novel pan-proteome array for high-throughput profiling of the humoral response to Treponema pallidum subsp. iScience. 2024;27(9):110618. doi: 10.1016/j.isci.2024.110618</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zhang X, Duan J, Wang Y, Xie B, Zhou J, Zhao S, et al. Insight into the invasion process and immune-protective evaluation of Tp0971, a membrane lipoprotein from Treponema pallidum. Microbiol Spectr. 2023;11(6):e0004723. doi: 10.1128/spectrum.00047-23</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Haynes AM, Konda KA, Romeis E, Siebert J, Vargas SK, Diaz MR, et al. Evaluation of a minimal array of Treponema pallidum antigens as biomarkers for syphilis diagnosis, infection staging, and response to treatment. Microbiol Spectr. 2024;12(1):e0346623. doi: 10.1128/spectrum.03466-23</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Deka RK, Brautigam CA, Tomson FL, Lumpkins SB, Tomchick DR, Machius M, et al. Crystal structure of the Tp34 (Tp0971) lipoprotein of Treponema pallidum: implications of its metal-bound state and affinityfor human lactoferrin. J Biol Chem. 2007;282(8):5944–5958. doi: 10.1074/jbc.M610215200</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Brautigam CA, Deka RK, Ouyang Z, Machius M, Knutsen G, Tomchick DR, et al. Biophysical and bioinformatic analyses implicate the Treponema pallidum Tp34 lipoprotein (Tp0971) in transition metal homeostasis. J Bacteriol. 2012;194(24):6771–6781. doi: 10.1128/JB.01494-12</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>ГОСТ Р 53022.3-2008. Национальный стандарт Российской Федерации. Технологии лабораторные клинические. Требования к качеству клинических лабораторных исследований. Часть 3. Правила оценки клинической информативности лабораторных тестов. URL: https://docs.cntd.ru/document/1200072565</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Liu W, Deng M, Zhang X, Yin W, Zhao T, Zeng T, et al. Performance of novel infection phase-dependent antigens in syphilis serodiagnosis and treatment efficacy determination. Clin Chim Acta. 2019;488:13–19. doi: 10.1016/j.cca.2018.10.017</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Ijsselmuiden OE, Beelaert G, Schouls LM, Tank B, Stolz E, van der Groen G. Line immunoassay and enzyme-linked line immunofiltration assay for simultaneous detection of antibody to two treponemal antigens. Eur J Clin Microbiol Infect Dis. 1989;8(8):716–721. doi: 10.1007/BF01963758</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Xu M, Xie Y, Jiang C, Xiao Y, Kuang X, Zhao F, et al. A novel ELISA using a recombinant outer membrane protein, rTp0663, as the antigen for serological diagnosis of syphilis. Int J Infect Dis. 2016;43:51–57. doi: 10.1016/j.ijid.2015.12.013</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Sun AH, Mao YF, Hu Y, Sun Q, Yan J. Sensitive and specific ELISA coated by TpN15–TpN17–TpN47 fusion protein for detection of antibodies to Treponema pallidum. Clin Chem Lab Med. 2009;47(3):321–326. doi: 10.1515/CCLM.2009.071</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Smith BC, Simpson Y, Morshed MG, Cowen LLE, Hof R, Wetherell C, et al. New proteins for a new perspective on syphilis diagnosis. J Clin Microbiol. 2013;51(1):105–111. doi: 10.1128/JCM.01390-12</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Silva AO, de Oliveira UD, Vasconcelos LCM, Foti L, Leony LM, Daltro RT, et al. Performance of Treponema pallidum recombinant proteins in the serological diagnosis of syphilis. PLoS One. 2020;15(6):e0234043. doi: 10.1371/journal.pone.0234043</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Silva AO, Lima AA, Vasconcelos LCM, Almeida RA, Freitas NEM, Oliva TA, et al. Evaluating the diagnostic accuracy of TpN17 and TmpA recombinant proteins in syphilis detection: a phase II study. Front Microbiol. 2024;15:1348437. doi: 10.3389/fmicb.2024.1348437</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Chen D, He SWY, Fu Y, Zhao F, Zhou X, Yin H, et al. Assessment of recombinant antigens Tp0100 and Tp1016 of Treponema pallidum for serological diagnosis of syphilis. J Clin Lab Anal. 2022;36(9):e24635. doi: 10.1002/jcla.24635</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>de Sá Queiroz JHF, Barbosa DSM, Miranda LGO, de Oliveira NR, Dellagostin OA, Marchioro SB, et al. Tp0684, Tp0750, and Tp0792 Recombinant proteins as antigens for the serodiagnosis of syphilis. Indian J Microbiol. 2022;62(3):419–427. doi: 10.1007/s12088-022-01017-w</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pastuszczak M, Kotnis-Gaska A, Jakubowicz B, Wojas-Pelc А. Treponema pallidum-specific immune responses and autoimmunity in patients who remain serofast after treatment of syphilis. Postepy Dermatol. Alergol. 2019;36(5):620–625. doi: 10.5114/ada.2018.77497</mixed-citation></ref></ref-list></back></article>
